Industry News_Lihero Pharmaceutical

Blog

Home page

Company News

Industry News

Media Coverage

What are pharmaceutical intermediates, APIs

The so-called pharmaceutical intermediates are actually some chemical raw materials or chemical products used in the process of drug synthesis.

2021

China Cephalosporin Drugs and Intermediates Market Analysis

Under the influence of the epidemic and the price reduction of the collection, the domestic cephalosporin drug market has a more obvious decline in the past three years, and in 2022 it was 57.555 billion yuan.

2021

Antibiotic intermediates: varieties of differentiation is obvious, industrial upgrading continues

Penicillins: prices are higher, 6-APA competition pattern eases. Penicillin intermediates mainly include penicillin industrial salt and 6-APA, penicillin industrial salt is widely used, 6-APA is an important intermediate for the production of semi-synthetic penicillin amoxicillin and ampicillin (sodium).

2021

Pharmaceutical intermediates have become an important link in the pharmaceutical industry chain

Pharmaceutical intermediates are important raw materials in the process of manufacturing drugs, and the quality of pharmaceutical intermediates directly determines the quality and effect of drugs.

2025

2024 medical insurance state talks: 91 kinds of drugs new enhancement catalogue, negotiation average price reduction of 63%

At the conference, the relevant person in charge of the National Health Insurance Bureau introduced that the scope of catalogue adjustment this year is mainly based on new medicines, and 90 of the 91 new medicines are newly listed varieties within five years.

2025

2023 China Pharmaceutical Enterprises R&D Achievement Index Released, Gaining Insight into the Industry's Innovation Pulse

Recently, the ‘2023 R&D Index of Chinese Pharmaceutical Enterprises’ was officially released at the 2024 China Pharmaceutical Industry Development Conference.

2025

The plenary session of the Executive Committee of the 12th Pharmacopoeia Commission was held to consider and adopt the 2025 edition of the Chinese Pharmacopoeia (Draft).

On 27 November, the plenary meeting of the Executive Committee of the Twelfth Pharmacopoeia Commission was held in Beijing to consider and adopt the 2025 version of the Pharmacopoeia of the People's Republic of China (Draft), and to deploy and promote the promulgation and implementation of the new version of the Pharmacopoeia.

2025

Benefiting a wider range of people National health insurance personal account cross-provincial mutual benefit work started

On 2 December, the National Bureau of Medical Security officially launched the cross-provincial sharing of national medical insurance personal accounts in Suzhou, Jiangsu Province.

2025

< 1 >

No.6 Qinghe Avenue, Zhumadian City, Henan Province

+86-396-2752586 +86-396-2752587

polly@lihero.cn

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

IPV6 SEO Business License